Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 232

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study

Open access
Lally, Peter J, Montaldo, Paolo, Oliveira, Vânia, Soe, Aung, Swamy, Ravi, Bassett, Paul, Mendoza, Josephine, Atreja, Gaurav, Kariholu, Ujwal, Pattnayak, Santosh, Sashikumar, Palaniappan, Harizaj, Helen, Mitchell, Martin, Ganesh, Vijayakumar, Harigopal, Sundeep, Dixon, Jennifer, English, Philip, Clarke, Paul, Muthukumar, Priya, Satodia, Prakash, Wayte, Sarah, Abernethy, Laurence J, Yajamanyam, Kiran, Bainbridge, Alan, Price, David, Huertas, Angela, Sharp, David J, Kalra, Vaneet, Chawla, Sanjay, Shankaran, Seetha, Thayyil, Sudhin, Lally, Peter J, Montaldo, Paolo, Oliveira, Vânia, Soe, Aung, Swamy, Ravi, Bassett, Paul, Mendoza, Josephine, Atreja, Gaurav, Kariholu, Ujwal, Pattnayak, Santosh, Sashikumar, Palaniappan, Harizaj, Helen, Mitchell, Martin, Ganesh, Vijayakumar, Harigopal, Sundeeep, Dixon, Jennifer, English, Philip, Clarke, Paul, Muthukumar, Priya, Satodia, Prakash, Wayte, Sarah, Abernethy, Laurence J, Yajamanyam, Kiran, Bainbridge, Alan, Price, David, Huertas, Angela, Sharp, David J, Kalra, Vaneet, Chawla, Sanjay, Shankaran, Seetha, Thayyil, Sudhin · 2019 · The Lancet Neurology

Abstract

BACKGROUND: In neonatal encephalopathy, the clinical manifestations of injury can only be reliably assessed several years after an intervention, complicating early prognostication and rendering trials of promising neuroprotectants slow and expensive. We aimed to determine the accuracy of thalamic proton magnetic resonance (MR) spectroscopy (MRS) biomarkers as early predictors of the neurodevelopmental abnormalities observed years after neonatal encephalopathy. METHODS: -weighted, and diffusion-weighted MRI and thalamic proton MRS 4-14 days after birth. Clinical neurodevelopmental tests were done 18-24 months later. The primary outcome was the association between MR biomarkers and an adverse neurodevelopmental outcome, defined as death or moderate or severe disability, measured using a multivariable prognostic model. We used receiver operating characteristic (ROC) curves to examine the prognostic accuracy of the individual biomarkers. This trial is registered with ClinicalTrials.gov, number NCT01309711. FINDINGS: Between Jan 29, 2013, and June 25, 2016, we recruited 223 infants who all underwent MRI and MRS at a median age of 7 days (IQR 5-10), with 190 (85%) followed up for neurological examination at a median age of 23 months (20-25). Of those followed up, 31 (16%) had moderate or severe disability, including one death. Multiple logistic regression analysis could not be done because thalamic N-acetylaspartate (NAA) concentration alone accurately predicted an adverse neurodevelopmental outcome (area under the curve [AUC] of 0·99 [95% CI 0·94-1·00]; sensitivity 100% [74-100]; specificity 97% [90-100]; n=82); the models would not converge when any additional variable was examined. The AUC (95% CI) of clinical examination at 6 h (n=190) and at discharge (n=167) were 0·72 (0·65-0·78) and 0·60 (0·53-0·68), respectively, and the AUC of abnormal amplitude integrated EEG at 6 h (n=169) was 0·73 (0·65-0·79). On conventional MRI (n=190), cortical injury had an AUC of 0·67 (0·60-0·73), basal ganglia or thalamic injury had an AUC of 0·81 (0·75-0·87), and abnormal signal in the posterior limb of internal capsule (PLIC) had an AUC of 0·82 (0·76-0·87). Fractional anisotropy of PLIC (n=65) had an AUC of 0·82 (0·76-0·87). MRS metabolite peak-area ratios (n=160) of NAA-creatine (<1·29) had an AUC of 0·79 (0·72-0·85), of NAA-choline had an AUC of 0·74 (0·66-0·80), and of lactate-NAA (>0·22) had an AUC of 0·94 (0·89-0·97). INTERPRETATION: Thalamic proton MRS measures acquired soon after birth in neonatal encephalopathy had the highest accuracy to predict neurdevelopment 2 years later. These methods could be applied to increase the power of neuroprotection trials while reducing their duration. FUNDING: National Institute for Health Research UK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(18)30325-9

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 232

Metadata

Authors
Lally, P. J., Montaldo, P., Oliveira, V., Soe, A., Swamy, R., Bassett, P., Mendoza, J., Atreja, G., Kariholu, U., Pattnayak, S., Sashikumar, P., Harizaj, H., Mitchell, M., Ganesh, V., Harigopal, S., Dixon, J., English, P., Clarke, P., Muthukumar, P., Satodia, P., Wayte, S., Abernethy, L. J., Yajamanyam, K., Bainbridge, A., Price, D., Huertas, A., Sharp, D. J., Kalra, V., Chawla, S., Shankaran, S., Thayyil, S., Lally, P. J., Montaldo, P., Oliveira, V., Soe, A., Swamy, R., Bassett, P., Mendoza, J., Atreja, G., Kariholu, U., Pattnayak, S., Sashikumar, P., Harizaj, H., Mitchell, M., Ganesh, V., Harigopal, S., Dixon, J., English, P., Clarke, P., Muthukumar, P., Satodia, P., Wayte, S., Abernethy, L. J., Yajamanyam, K., Bainbridge, A., Price, D., Huertas, A., Sharp, D. J., Kalra, V., Chawla, S., Shankaran, S., & Thayyil, S.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2019-01
Volume
18
Issue
1
Pages
35-45
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2900490565
Cited by
232
References
1
FWCI
23.06
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study. https://app.cochat.ai/papers/10.1016/s1474-4422(18)30325-9
The paper
Lally, P. J., Montaldo, P., Oliveira, V., Soe, A., Swamy, R., Bassett, P., Mendoza, J., Atreja, G., Kariholu, U., Pattnayak, S., Sashikumar, P., Harizaj, H., Mitchell, M., Ganesh, V., Harigopal, S., Dixon, J., English, P., Clarke, P., Muthukumar, P., . . . Thayyil, S. (2019). Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(18)30325-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.